Safety and immunogenicity of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine in adults and children in Vellore, South India

This open-label study assessed the safety and immunogenicity of two doses (14 days apart) of an indigenously manufactured, killed, bivalent (Vibrio cholerae O1 and O139), whole-cell oral cholera vaccine (SHANCHOL; Shantha Biotechnics) in healthy adults (n = 100) and children (n = 100) in a cholera e...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS One
Autors principals: Raghava Mohan, Venkata, Raj, Santosh, Dhingra, Mandeep Singh, Aloysia D’Cor, Naveena, Singh, Ajit Pal, Saluja, Tarun, Kim, Deok Ryun, Midde, Venkat Jayanth, Kim, Yanghee, Vemula, Sridhar, Narla, Santhosh Kumar, Sah, Binod, Ali, Mohammad
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2019
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6581248/
https://ncbi.nlm.nih.gov/pubmed/31211792
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0218033
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars